Trial Details

COMPLETED
Basic Information
Clinical ID c1449
Identifier NCT00928681
Trial Title A Study To Investigate The Safety And Efficacy Properties Of PF-00547659 In Patients With Active Ulcerative Colitis
Trial URL Visit Original Page
Study Information
Study Results

NO
Conditions Colitis, Ulcerative
Interventions BIOLOGICAL: Single dose-group A|BIOLOGICAL: Single dose-group A|BIOLOGICAL: Multiple dose- Group B|BIOLOGICAL: Single dose-group A|BIOLOGICAL: Multiple dose- Group B|BIOLOGICAL: Single dose-group A|BIOLOGICAL: Single dose-group A|BIOLOGICAL: Single dose-group A|BIOLOGICAL: Single dose-group A|BIOLOGICAL: Multiple dose-Group B|BIOLOGICAL: Multiple dose- Group B|BIOLOGICAL: Multiple dose- Group B|BIOLOGICAL: Multiple dose- Group B|BIOLOGICAL: Multiple dose- Group B|BIOLOGICAL: Multiple dose-Group B
Participant Information
Sponsor Pfizer
City Brussels
Country/Region Belgium
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE1
Time Information
Start Date 2025-09-05
Primary Completion Date 2025-04-08
Completion Date 2025-10-08